日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pan-cancer profiling of FZD2 as a prognostic biomarker: integrative multi-omics analysis with experimental validation and functional characterization in gastric cancer.

FZD2 作为预后生物标志物的泛癌分析：整合多组学分析、实验验证和胃癌功能表征

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1534974
Zhou Sijiang, Li Da, Quan Chao, Yu Zhu, Feng Yue, Wang Shengyu, Li Yong, Qi Tongtong, Chen Junqiang
肿瘤
胃癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting

利用亚细胞靶向技术提高癌症治疗效果的纳米药物精确设计策略

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-020-00342-0
Fu, Xianglei; Shi, Yanbin; Qi, Tongtong; Qiu, Shengnan; Huang, Yi; Zhao, Xiaogang; Sun, Qifeng; Lin, Guimei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Research Progress on the Anti-Cancer Molecular Mechanisms of Huaier

淮尔抗癌分子机制的研究进展

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S281328
Qi, Tongtong; Dong, Yonghong; Gao, Zili; Xu, Jun
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway

合成并发现通过抑制TGF-β1通路治疗特发性肺纤维化的候选药物

期刊:European Journal of Medicinal Chemistry
影响因子:6
doi:10.1016/j.ejmech.2018.07.074
Xiaohe Li, Cheng Lu, Shuangwei Liu, Shuaishuai Liu, Chengcheng Su, Ting Xiao, Zhun Bi, Pengzhen Sheng, Mengying Huang, Xinhua Liu, Yujiao Wei, Lin Zhao, Shengxiang Miao, Jiahe Mao, Kai Huang, Shaoyan Gao, Ning Liu, Min Qi, Tongtong Liu, Shuanglin Qin, Luqing Wei, Tao Sun, Wen Ning, Guang Yang, Hongg
信号转导
TGF-β
发表日期：2018
文献求助 收藏

Functional Polymorphisms in IRAKs Are Related to Hepatocellular Carcinoma Risk in Chinese Population

IRAKs功能性多态性与中国人群肝细胞癌风险相关

期刊:Biomed Research International
影响因子:2.6
doi:10.1155/2018/1252849.
Hui Wang,Ci Song,Qi Qi,Tongtong Huang,Lijuan Wang,Jianguo Chen,Jian Zhu,Zhibin Hu,Juncheng Dai
肝癌
细胞生物学
肿瘤
发表日期：2018
文献求助 收藏